{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:22:14Z","timestamp":1791235334946,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,6,20]],"date-time":"2007-06-20T00:00:00Z","timestamp":1182297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,6,20]],"date-time":"2007-06-20T00:00:00Z","timestamp":1182297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1007\/s11926-007-0034-x","type":"journal-article","created":{"date-parts":[[2007,6,19]],"date-time":"2007-06-19T00:30:51Z","timestamp":1182213051000},"page":"212-218","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Antiphospholipid antibodies in response to infection"],"prefix":"10.1007","volume":"9","author":[{"given":"Tadej","family":"Av\u010din","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nata\u0161a","family":"Toplak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,6,20]]},"reference":[{"key":"34_CR1","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1056\/NEJMra002974","volume":"346","author":"J.S. Levine","year":"2002","unstructured":"Levine JS, Branch DW, Rauch J: The antiphospholipid syndrome. N Engl J Med 2002, 346:752\u2013763.","journal-title":"N Engl J Med"},{"key":"34_CR2","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1136\/ard.2003.014175","volume":"63","author":"R. Cervera","year":"2004","unstructured":"Cervera R, Asherson RA, Acevedo ML, et al.: Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients. Ann Rheum Dis 2004, 63:1312\u20131317.","journal-title":"Ann Rheum Dis"},{"key":"34_CR3","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1136\/ard.2005.045443","volume":"65","author":"Y. Shoenfeld","year":"2006","unstructured":"Shoenfeld Y, Blank M, Cervera R, et al.: Infectious origin of the antiphospholipid syndrome. Ann Rheum Dis 2006, 65:2\u20136.","journal-title":"Ann Rheum Dis"},{"key":"34_CR4","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1161\/01.STR.32.8.1707","volume":"32","author":"T.H. Luong","year":"2001","unstructured":"Luong TH, Rand JH, Wu XX, et al.: Seasonal distribution of antiphospholipid antibodies. Stroke 2001, 32:1707\u20131711.","journal-title":"Stroke"},{"key":"34_CR5","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/rheumatology\/40.5.565","volume":"40","author":"T. Avcin","year":"2001","unstructured":"Avcin T, Ambrozic A, Kuhar M, et al.: Anticardiolipin and anti-beta2 glycoprotein I antibodies in sera of 61 apparently healthy children at regular preventive visits. Rheumatology 2001, 40:565\u2013573.","journal-title":"Rheumatology"},{"key":"34_CR6","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2141.1995.tb05324.x","volume":"91","author":"T. McNally","year":"1995","unstructured":"McNally T, Purdy G, Mackie IJ, et al.: The use of an anti-beta2-glycoprotein-I assay for discrimination between anticardiolipin antibodies associated with infection and increased risk of thrombosis. Br J Haematol 1995, 91:471\u2013473.","journal-title":"Br J Haematol"},{"key":"34_CR7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/00005792-200111000-00002","volume":"80","author":"R.A. Asherson","year":"2001","unstructured":"Asherson RA, Cervera R, Piette JC, et al.: Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine 2001, 80:355\u2013377.","journal-title":"Medicine"},{"key":"34_CR8","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3109\/08880019809014016","volume":"15","author":"C. Kratz","year":"1998","unstructured":"Kratz C, Mauz-K\u00f6rholz C, Kruck H, et al.: Detection of antiphospholipid antibodies in children and adolescents. Pediatr Hematol Oncol 1998, 15:325\u2013332.","journal-title":"Pediatr Hematol Oncol"},{"key":"34_CR9","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.imbio.2005.10.012","volume":"210","author":"K. Frauenknecht","year":"2005","unstructured":"Frauenknecht K, Lackner K, von Landenberg P: Antiphospholipid antibodies in pediatric patients with prolonged activated partial thromboplastin time during infection. Immunobiology 2005, 210:799\u2013805.","journal-title":"Immunobiology"},{"key":"34_CR10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/0090-1229(86)90046-2","volume":"41","author":"O. Vaarala","year":"1986","unstructured":"Vaarala O, Palosuo T, Kleemola M, Aho K: Anticardiolipin response in acute infections. Clin Immunol Immunopathol 1986, 41:8\u201315.","journal-title":"Clin Immunol Immunopathol"},{"key":"34_CR11","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1002\/art.11038","volume":"48","author":"P. Von Landenberg","year":"2003","unstructured":"Von Landenberg P, Lehmann HW, Knoll A, et al.: Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection. Arthritis Rheum 2003, 48:1939\u20131947.","journal-title":"Arthritis Rheum"},{"key":"34_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/art.1780400115","volume":"40","author":"S. Loizou","year":"1997","unstructured":"Loizou S, Cazabon JK, Walport MJ, et al.: Similarities of specificity and cofactor dependence in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus. Arthritis Rheum 1997, 40:103\u2013108.","journal-title":"Arthritis Rheum"},{"key":"34_CR13","first-page":"2335","volume":"28","author":"M. Kalt","year":"2001","unstructured":"Kalt M, Gertner E: Antibodies to beta2-glycoprotein I and cardiolipin with symptoms suggestive of systemic lupus erythematosus in parvovirus B19 infection. J Rheumatol 2001, 28: 2335\u20132336.","journal-title":"J Rheumatol"},{"key":"34_CR14","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/S0002-9343(00)00561-1","volume":"109","author":"T. Reitblat","year":"2000","unstructured":"Reitblat T, Drogenikov T, Sigalov I, et al.: Transient anticardiolipin antibody syndrome in a patient with parvovirus B19 infection. Am J Med 2000, 109:512\u2013513.","journal-title":"Am J Med"},{"key":"34_CR15","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s10067-005-0032-1","volume":"25","author":"Y. Asano","year":"2006","unstructured":"Asano Y, Sarukawa M, Idezuki T, et al.: Multiple small pulmonary emboli associated with transitient antiphospholipid syndrome in human parvovirus B19 infection. Clin Rheumatol 2006, 25:585\u2013587.","journal-title":"Clin Rheumatol"},{"key":"34_CR16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/clinids\/24.2.197","volume":"24","author":"J.A. Labarca","year":"1997","unstructured":"Labarca JA, Rabaggliati RM, Radrigan FJ, et al.: Antiphospholipid syndrome associated with cytomegalovirus infection: case report and review. Clin Infect Dis 1997, 24:197\u2013200.","journal-title":"Clin Infect Dis"},{"key":"34_CR17","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1191\/096120399678841034","volume":"8","author":"I. Uthman","year":"1999","unstructured":"Uthman I, Tabbarah Z, Gharavi AE: Hughes syndrome associated with cytomegalovirus infection. Lupus 1999, 8:775\u2013777.","journal-title":"Lupus"},{"key":"34_CR18","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1016\/j.jinf.2006.03.031","volume":"54","author":"V. Delbos","year":"2007","unstructured":"Delbos V, Abgueguen P, Chennebault JM, et al.: Acute cytomegalovirus infection and venous thrombosis: role of antiphospholipid antibodies. J Infect 2007, 54:e47\u201350.","journal-title":"J Infect"},{"key":"34_CR19","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1177\/096120330000900716","volume":"9","author":"V. Viseux","year":"2000","unstructured":"Viseux V, Darnige L, Carmi E, et al.: Pulmonary embolism and transitory anti-beta2-GPI antibodies in an adult with chicken pox. Lupus 2000, 9:558\u2013560.","journal-title":"Lupus"},{"key":"34_CR20","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jcv.2004.07.013","volume":"32","author":"S. Van Hal","year":"2005","unstructured":"Van Hal S, Senanayake S, Hardiman R: Splenic infarction due to transient antiphospholipid antibodies induced by acute Epstein-Barr virus infection. J Clin Virol 2005, 32:245\u2013247.","journal-title":"J Clin Virol"},{"key":"34_CR21","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.braindev.2005.11.002","volume":"28","author":"G. Losurdo","year":"2006","unstructured":"Losurdo G, Giacchino R, Castagnola E, et al.: Cerebrovascular disease and varicella in children. Brain Dev 2006, 28:366\u2013370.","journal-title":"Brain Dev"},{"key":"34_CR22","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0022-3476(96)70274-3","volume":"128","author":"M.J. Manco-Johnson","year":"1996","unstructured":"Manco-Johnson MJ, Nuss R, Key N, et al.: Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis. J Pediatr 1996, 128:319\u2013323.","journal-title":"J Pediatr"},{"key":"34_CR23","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1159\/000077315","volume":"208","author":"A. Campanelli","year":"2004","unstructured":"Campanelli A, Kaya G, Ozsahin AH, et al.: Purpura fulminans in a child as a complication of chickenpox infection. Dermatology 2004, 208:262\u2013264.","journal-title":"Dermatology"},{"key":"34_CR24","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1128\/CDLI.7.2.241-244.2000","volume":"7","author":"J. Ordi-Ros","year":"2000","unstructured":"Ordi-Ros J, Villarreal J, Monegal F, et al.: Anticardiolipin antibodies in patients with chronic hepatitis C virus infection: characterization in relation to antiphospholipid syndrome. Clin Diagn Lab Immunol 2000, 7:241\u2013244.","journal-title":"Clin Diagn Lab Immunol"},{"key":"34_CR25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/00042737-200012010-00013","volume":"12","author":"G.N. Dalekos","year":"2000","unstructured":"Dalekos GN, Kistis KG, Boumba DS, et al.: Increased incidence of anti-cardiolipin antibodies in patients with hepatitis C is not associated with aetiopathogenetic link to anti-phospholipid syndrome. Eur J Gastroenterol Hepatol 2000, 12:67\u201374.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"34_CR26","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1046\/j.1365-2362.2003.01110.x","volume":"33","author":"K. Zachou","year":"2003","unstructured":"Zachou K, Liaskos C, Christodoulou DK, et al.: Anti-cardiolipin antibodies in patients with chronic viral hepatitis are independent of beta2-glycoprotein I cofactor or features of antiphospholipid syndrome. Eur J Clin Invest 2003, 33:161\u2013168.","journal-title":"Eur J Clin Invest"},{"key":"34_CR27","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/S0168-8278(99)80127-5","volume":"30","author":"F.J. Mu\u00f1oz-Rodr\u00edguez","year":"1999","unstructured":"Mu\u00f1oz-Rodr\u00edguez FJ, Tassies D, Font J, et al.: Prevalence of hepatitis C virus infection in patients with antiphospholipid syndrome. J Hepatol 1999, 30:770\u2013773.","journal-title":"J Hepatol"},{"key":"34_CR28","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s005350050345","volume":"35","author":"M. Harada","year":"2000","unstructured":"Harada M, Fujisawa Y, Sakisaka S, et al.: High prevalence of anticardiolipin antibodies in hepatitis C virus infection: lack of effects on thrombocytopenia and thrombotic complications. J Gastroenterol 2000, 35:272\u2013277.","journal-title":"J Gastroenterol"},{"key":"34_CR29","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1097\/00006454-200108000-00020","volume":"20","author":"D. Ertem","year":"2001","unstructured":"Ertem D, Acar Y, Pehlivanoglu E: Autoimmune complications associated with hepatitis A virus infection in children. Pediatr Infect Dis J 2001, 20:809\u2013811.","journal-title":"Pediatr Infect Dis J"},{"key":"34_CR30","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1136\/ard.60.5.500","volume":"60","author":"H. Guglielmone","year":"2001","unstructured":"Guglielmone H, Vitozzi S, Elbarcha O, Fernandez E: Cofactor dependence and isotype distribution of anticardiolipin antibodies in viral infections. Ann Rheum Dis 2001, 60:500\u2013504.","journal-title":"Ann Rheum Dis"},{"key":"34_CR31","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1001\/jama.256.4.491","volume":"256","author":"E.J. Bloom","year":"1986","unstructured":"Bloom EJ, Abrams DI, Rodgers G: Lupus anticoagulant in the acquired immunodeficiency syndrome. JAMA 1986, 256:491\u2013493.","journal-title":"JAMA"},{"key":"34_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0049-3848(99)00059-6","volume":"96","author":"G.F. De Larranaga","year":"1999","unstructured":"De Larranaga GF, Forastiero RR, Carreras LO, Alonso BS: Different types of antiphospholipid antibodies in AIDS: a comparison with syphilis and the antiphospholipid syndrome. Thromb Res 1999, 96:19\u201325.","journal-title":"Thromb Res"},{"key":"34_CR33","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1089\/1087291041444032","volume":"18","author":"A. Hassoun","year":"2004","unstructured":"Hassoun A, Al-Kadhimi Z, Cervia J: HIV infection and antiphospholipid antibody: literature review and link to the antiphospholipid syndrome. AIDS Patient Care STDS 2004, 18:333\u2013340.","journal-title":"AIDS Patient Care STDS"},{"key":"34_CR34","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/01.inf.0000200140.04406.d0","volume":"25","author":"I. Shah","year":"2006","unstructured":"Shah I, Chudgar P: Antiphospholipid syndrome in a human immunodeficiency virus 1-infected child. Pediatr Infect Dis J 2006, 25:185\u2013186.","journal-title":"Pediatr Infect Dis J"},{"key":"34_CR35","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1001\/archderm.131.3.357","volume":"131","author":"K.J. Smith","year":"1995","unstructured":"Smith KJ, Skelton HG, Yeager J, Wagner KF: Cutaneous thrombosis in human immunodeficiency virus type 1-positive patients and cytomegalovirus viremia. Arch Dermatiol 1995, 131:357\u2013358.","journal-title":"Arch Dermatiol"},{"key":"34_CR36","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1006\/jaut.1999.0324","volume":"13","author":"C. Petrovas","year":"1999","unstructured":"Petrovas C, Vlachoyiannopoulos PG, Kordossis T, Moutsopoulos HM: Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI. J Autoimmun 1999, 13:347\u2013355.","journal-title":"J Autoimmun"},{"key":"34_CR37","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1159\/000045472","volume":"83","author":"L. Ardiles","year":"1999","unstructured":"Ardiles L, Ramirez P, Moya P, et al.: Anticardiolipin antibodies in acute poststreptococcal glomerulonephritis and streptococcal impetigo. Nephron 1999, 83:47\u201352.","journal-title":"Nephron"},{"key":"34_CR38","first-page":"1175","volume":"19","author":"F. Figueroa","year":"1992","unstructured":"Figueroa F, Berrios X, Gutierrez M, et al.: Anticardiolipin antibodies in acute rheumatic fever. J Rheumatol 1992, 19:1175\u20131180.","journal-title":"J Rheumatol"},{"key":"34_CR39","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1191\/096120301701548526","volume":"10","author":"H. Ilarraza","year":"2001","unstructured":"Ilarraza H, Marquez MF, Alcocer A, et al.: Anticardiolipin antibodies are not associated with rheumatic heart disease. Lupus 2001, 10:873\u2013875.","journal-title":"Lupus"},{"key":"34_CR40","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/pgmj.66.775.356","volume":"66","author":"N. Snowden","year":"1990","unstructured":"Snowden N, Wilson PB, Longson M, Pumphrey RS: Antiphospholipid antibodies and Mycoplasma pneumoniae infection. Postgrad Med J 1990, 66:356\u2013362.","journal-title":"Postgrad Med J"},{"key":"34_CR41","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1191\/0961203306lu2258cr","volume":"15","author":"M. Bakshi","year":"2006","unstructured":"Bakshi M, Khemani C, Vishwanathan V, et al.: Mycoplasma pneumonia with antiphospholipid antibodies and a cardiac thrombus. Lupus 2006, 15:105\u2013106.","journal-title":"Lupus"},{"key":"34_CR42","doi-asserted-by":"publisher","first-page":"e292","DOI":"10.1542\/peds.2006-1340","volume":"119","author":"C.M. Witmer","year":"2007","unstructured":"Witmer CM, Steenhoff AP, Shah SS, Raffini LJ: Mycoplasma pneumoniae, splenic infarct, and transient antiphospholipid antibodies: a new association?\n                           Pediatrics 2007, 119:e292\u2013295.","journal-title":"Pediatrics"},{"key":"34_CR43","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1542\/peds.2005-0433","volume":"116","author":"N.A. Goldenberg","year":"2005","unstructured":"Goldenberg NA, Knapp-Clevenger R, Hays T, Manco-Johnson MJ: Lemierre\u2019s and Lemierre\u2019s-like syndromes in children: survival and thromboembolic outcomes. Pediatrics 2005, 116:543\u2013548.","journal-title":"Pediatrics"},{"key":"34_CR44","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1177\/096120339400300615","volume":"3","author":"M. Hojnik","year":"1994","unstructured":"Hojnik M, Gilburd B, Ziporen L, et al.: Anticardiolipin antibodies in infections are heterogenous in their dependency on beta2-glycoprotein I: analysis of anticardiolipin antibodies in leprosy. Lupus 1994, 3:515\u2013521.","journal-title":"Lupus"},{"key":"34_CR45","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1191\/096120300678828712","volume":"9","author":"G.F. De Larranaga","year":"2000","unstructured":"De Larranaga GF, Forastiero RR, Martinuzzo ME, et al.: High prevalence of antiphospholipid antibodies in leprosy: evaluation of antigen reactivity. Lupus 2000, 9:594\u2013600.","journal-title":"Lupus"},{"key":"34_CR46","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1046\/j.1365-2249.2002.01722.x","volume":"127","author":"P.H. Consigny","year":"2002","unstructured":"Consigny PH, Cauquelin B, Agnamey P, et al.: High prevalence of co-factor independent anticardiolipin antibodies in malaria exposed individuals. Clin Exp Immunol 2002, 127:158\u2013164.","journal-title":"Clin Exp Immunol"},{"key":"34_CR47","first-page":"425","volume":"19","author":"M. Santiago","year":"2001","unstructured":"Santiago M, Martinelli R, Ko A, et al.: Anti-beta2 glycoprotein I and anticardiolipin antibodies in leptospirosis, syphilis and Kala-azar. Clin Exp Rheumatol 2001, 19:425\u2013430.","journal-title":"Clin Exp Rheumatol"},{"key":"34_CR48","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1365-2249.2005.02923.x","volume":"142","author":"J. Martinuc-Porobic","year":"2005","unstructured":"Martinuc-Porobic J, Avcin T, Bozic B, et al.: Anti-phospholipid antibodies following vaccination with recombinant hepatitis B vaccine. Clin Exp Immunol 2005, 142:377\u2013380.","journal-title":"Clin Exp Immunol"},{"key":"34_CR49","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/03009740500474552","volume":"35","author":"P. Tarjan","year":"2006","unstructured":"Tarjan P, Sipka S, Lakos G, et al.: Influenza vaccination and the production of anti-phospholipid antibodies in patients with systemic lupus erythematosus. Scand J Rheumatol 2006, 35:241\u2013249.","journal-title":"Scand J Rheumatol"},{"key":"34_CR50","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.vaccine.2004.07.029","volume":"23","author":"R. Mormile","year":"2004","unstructured":"Mormile R, D\u2019Alterio V, Treccagnoli G, Sorrentino P: Henoch-Schonlein purpura with antiphospholipid antibodies after influenza vaccination: how fearful is it in children?\n                           Vaccine 2004, 23:567\u2013568.","journal-title":"Vaccine"},{"key":"34_CR51","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1023\/B:JOCI.0000018058.28764.ce","volume":"24","author":"M. Blank","year":"2004","unstructured":"Blank M, Asherson RA, Cervera R, Shoenfeld Y: Antiphospholipid syndrome infectious origin. J Clin Immunol 2004. 24:12\u201323.","journal-title":"J Clin Immunol"},{"key":"34_CR52","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1172\/JCI200212337","volume":"109","author":"M. Blank","year":"2002","unstructured":"Blank M, Krause I, Fridkin M, et al.: Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J Clin Invest 2002, 109:797\u2013804.","journal-title":"J Clin Invest"},{"key":"34_CR53","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/art.10130","volume":"46","author":"A.E. Gharavi","year":"2002","unstructured":"Gharavi AE, Pierangeli SS, Espinola RG, et al.: Antiphospholipid antibodies induced in mice by immunization with cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in vivo. Arthritis Rheum 2002, 46:545\u2013552.","journal-title":"Arthritis Rheum"},{"key":"34_CR54","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1182\/blood-2002-08-2349","volume":"101","author":"E. Raschi","year":"2003","unstructured":"Raschi E, Testoni C, Bosisio D, et al.: Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies. Blood 2003, 101:3495\u20133500.","journal-title":"Blood"},{"key":"34_CR55","doi-asserted-by":"crossref","unstructured":"Pierangeli SS, Vega-Ostertag ME, Raschi E, et al.: Toll like receptor 4 is involved in antiphospholipid-mediated thrombosis: in vivo studies. Ann Rheum Dis 2007, in press.","DOI":"10.1136\/ard.2006.065037"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-007-0034-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11926-007-0034-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-007-0034-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-007-0034-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T12:47:40Z","timestamp":1652618860000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11926-007-0034-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,20]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["34"],"URL":"https:\/\/doi.org\/10.1007\/s11926-007-0034-x","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,20]]},"assertion":[{"value":"20 June 2007","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}